Loading...

Vipul Jain, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentDean's Office
Address1001 Potrero Ave
San Francisco CA 94110
Phone559-499-6400
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency

    Collapse Overview 
    Collapse Overview
    Vipul Jain, M.D.
    Professor of Clinical Medicine, UCSF
    Chronic Lung Disease Program Director, Community Regional Medical Center

    Vipul Jain, M.D., specializes in pulmonary & critical care medicine. He is board certified in internal medicine, pulmonary and critical care medicine.

    Dr. Jain completed his internal medicine residency at UCSF Fresno and a fellowship in pulmonary and critical care medicine at the University of California, San Diego.

    Dr. Jain is a member of the American College of Physicians and the Society of Critical Care Medicine.


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Jalota L, Allison DR, Prajapati V, Vempilly JJ, Jain VV. Ability of Exhaled Nitric Oxide to Discriminate for Airflow Obstruction Among Frequent Exacerbators of Clinically Diagnosed Asthma. Lung. 2018 Jun 18. PMID: 29916097.
      View in: PubMed
    2. Jain VV, Stringer W. Reassessment of an Asthma Diagnosis. JAMA. 2017 05 02; 317(17):1801-1802. PMID: 28464136.
      View in: PubMed
    3. Tiwari A, Rahman K, Abejie B, Jain VV, Vempilly JJ. Longer duration of asthma is significantly associated with increased RV/TLC ratio. Respir Med. 2017 03; 124:44-48. PMID: 28284320.
      View in: PubMed
    4. Jalota L, Jain VV. Action plans for COPD: strategies to manage exacerbations and improve outcomes. Int J Chron Obstruct Pulmon Dis. 2016; 11:1179-88. PMID: 27330286; PMCID: PMC4898028.
    5. Bambra G, Jalota L, Kapoor C, Mills PK, Vempilly JJ, Jain VV. Office spirometry correlates with laboratory spirometry in patients with symptomatic asthma and COPD. Clin Respir J. 2017 Nov; 11(6):805-811. PMID: 26620598.
      View in: PubMed
    6. Jain VV, Allison DR, Andrews S, Mejia J, Mills PK, Peterson MW. Misdiagnosis Among Frequent Exacerbators of Clinically Diagnosed Asthma and COPD in Absence of Confirmation of Airflow Obstruction. Lung. 2015 Aug; 193(4):505-12. PMID: 25921015.
      View in: PubMed
    7. Jain VV, Allison R, Beck SJ, Jain R, Mills PK, McCurley JW, Van Gundy KP, Peterson MW. Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD. Respir Med. 2014 Dec; 108(12):1794-800. PMID: 25294691.
      View in: PubMed
    8. Jain VV, Abejie B, Bashir MH, Tyner T, Vempilly J. Lung volume abnormalities and its correlation to spirometric and demographic variables in adult asthma. J Asthma. 2013 Aug; 50(6):600-5. PMID: 23521185.
      View in: PubMed
    9. Jain VV, Perkins DL, Finn PW. Costimulation and allergic responses: immune and bioinformatic analyses. Pharmacol Ther. 2008 Mar; 117(3):385-92. PMID: 18280573.
      View in: PubMed
    10. Lu X, Jain VV, Finn PW, Perkins DL. Hubs in biological interaction networks exhibit low changes in expression in experimental asthma. Mol Syst Biol. 2007; 3:98. PMID: 17437023; PMCID: PMC1865580.
    11. Jen KY, Jain VV, Makani S, Finn PW. Immunomodulation of allergic responses by targeting costimulatory molecules. Curr Opin Allergy Clin Immunol. 2006 Dec; 6(6):489-94. PMID: 17088657.
      View in: PubMed
    12. Jain VV, Evans T, Peterson MW. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area. Respir Med. 2006 Jul; 100(7):1291-3. PMID: 16545951.
      View in: PubMed
    13. Jain VV, Kline JN. CpG DNA: immunomodulation and remodelling of the asthmatic airway. Expert Opin Biol Ther. 2004 Sep; 4(9):1533-40. PMID: 15335319.
      View in: PubMed
    14. Hussain I, Jain VV, O'Shaughnessy P, Businga TR, Kline J. Effect of nitrogen dioxide exposure on allergic asthma in a murine model. Chest. 2004 Jul; 126(1):198-204. PMID: 15249463.
      View in: PubMed
    15. Jain VV, Businga TR, Kitagaki K, George CL, O'Shaughnessy PT, Kline JN. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol Lung Cell Mol Physiol. 2003 Nov; 285(5):L1137-46. PMID: 12857672.
      View in: PubMed
    16. Jain VV, Kitagaki K, Businga T, Hussain I, George C, O'shaughnessy P, Kline JN. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J Allergy Clin Immunol. 2002 Dec; 110(6):867-72. PMID: 12464952.
      View in: PubMed
    17. Kitagaki K, Jain VV, Businga TR, Hussain I, Kline JN. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses. Clin Diagn Lab Immunol. 2002 Nov; 9(6):1260-9. PMID: 12414759; PMCID: PMC130087.
    18. Hussain I, Jain VV, Kitagaki K, Businga TR, O'Shaughnessy P, Kline JN. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides. Laryngoscope. 2002 Oct; 112(10):1819-26. PMID: 12368622.
      View in: PubMed
    19. Kline JN, Kitagaki K, Businga TR, Jain VV. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am J Physiol Lung Cell Mol Physiol. 2002 Jul; 283(1):L170-9. PMID: 12060574.
      View in: PubMed